|
US4977081A
(en)
|
1987-05-04 |
1990-12-11 |
Adi Diagnostics, Inc. |
Stable rabbit-mouse hybridomas and secretion products thereof
|
|
WO1989007142A1
(en)
|
1988-02-05 |
1989-08-10 |
Morrison Sherie L |
Domain-modified constant region antibodies
|
|
WO1990002569A1
(en)
|
1988-09-06 |
1990-03-22 |
International Genetic Engineering, Inc. |
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
|
US5574205A
(en)
|
1989-07-25 |
1996-11-12 |
Cell Genesys |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
|
WO1991008216A1
(en)
|
1989-12-01 |
1991-06-13 |
Genpharm International, Inc. |
Production of recombinant polypeptides by bovine species and transgenic methods
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
CA2050918A1
(en)
|
1990-01-12 |
1991-07-13 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
|
US5411881A
(en)
|
1990-07-10 |
1995-05-02 |
Nkk Corporation |
Chicken-specific immunoglobulin G-producing hybridoma
|
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
WO1994025585A1
(en)
|
1993-04-26 |
1994-11-10 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69133476T2
(de)
|
1990-08-29 |
2006-01-05 |
GenPharm International, Inc., Palo Alto |
Transgene Mäuse fähig zur Produktion heterologer Antikörper
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
CA2078539C
(en)
|
1991-09-18 |
2005-08-02 |
Kenya Shitara |
Process for producing humanized chimera antibody
|
|
US7067284B1
(en)
|
1992-01-27 |
2006-06-27 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
SG48760A1
(en)
|
1992-07-24 |
2003-03-18 |
Abgenix Inc |
Generation of xenogenetic antibodies
|
|
JPH08500017A
(ja)
|
1992-08-17 |
1996-01-09 |
ジェネンテク，インコーポレイテッド |
二特異的免疫アドヘジン
|
|
EP0583980A1
(en)
|
1992-08-20 |
1994-02-23 |
Eli Lilly And Company |
Method for generating monoclonal antibodies from rabbits
|
|
ATE203767T1
(de)
|
1992-08-21 |
2001-08-15 |
Univ Bruxelles |
Immunoglobuline ohne leichte ketten
|
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
HUT71790A
(en)
|
1992-12-01 |
1996-02-28 |
Protein Design Labs |
Humanized antibodies reactive with l-selectin
|
|
ATE204325T1
(de)
|
1993-04-29 |
2001-09-15 |
Unilever Nv |
Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae
|
|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
WO1995017500A1
(en)
|
1993-12-23 |
1995-06-29 |
Abs Global, Inc. |
Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
|
|
EP1231268B1
(en)
|
1994-01-31 |
2005-07-27 |
Trustees Of Boston University |
Polyclonal antibody libraries
|
|
US7119248B1
(en)
|
1994-04-12 |
2006-10-10 |
Miltenyi Biotec Gmbh |
Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
|
|
US6080560A
(en)
|
1994-07-25 |
2000-06-27 |
Monsanto Company |
Method for producing antibodies in plant cells
|
|
US6111166A
(en)
|
1994-09-19 |
2000-08-29 |
Medarex, Incorporated |
Transgenic mice expressing human Fcα and β receptors
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US6632976B1
(en)
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
|
AU7326796A
(en)
|
1995-10-30 |
1997-05-22 |
Spectral Diagnostics Inc. |
Stable chicken b-cell line and method of use thereof
|
|
US5716081A
(en)
|
1996-03-11 |
1998-02-10 |
Automotive Products (Usa), Inc. |
Spring clip for quick connect coupling
|
|
CA2250830A1
(en)
|
1996-06-26 |
1997-12-31 |
Binhai Zheng |
Chromosomal rearrangement by insertion of two recombination substrates
|
|
DK0826696T3
(da)
|
1996-09-03 |
2002-09-23 |
Gsf Forschungszentrum Umwelt |
Anvendelse af bi- og trispecifikke antistoffer til inducering af en tumorimmunitet
|
|
DK1500329T3
(da)
|
1996-12-03 |
2012-07-09 |
Amgen Fremont Inc |
Humane antistoffer, der specifikt binder TNF-alfa
|
|
US6080910A
(en)
|
1997-02-20 |
2000-06-27 |
Case Western Reserve University |
Transgenic knockout animals lacking IgG3
|
|
WO1998039416A1
(en)
|
1997-03-06 |
1998-09-11 |
Infigen, Inc. |
Method of cloning animals
|
|
CN1203922A
(zh)
|
1997-03-21 |
1999-01-06 |
三共株式会社 |
人源化抗人fas抗体
|
|
WO1998046645A2
(en)
|
1997-04-14 |
1998-10-22 |
Micromet Gesellschaft Für Biomedizinische Forschung Mbh |
Method for the production of antihuman antigen receptors and uses thereof
|
|
AU751659B2
(en)
|
1997-05-02 |
2002-08-22 |
Genentech Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US6774279B2
(en)
|
1997-05-30 |
2004-08-10 |
Carnegie Institution Of Washington |
Use of FLP recombinase in mice
|
|
NZ503489A
(en)
|
1997-10-03 |
2002-11-26 |
Chugai Pharmaceutical Co Ltd |
Natural humanized antibody, method of production and pharmaceutical composition
|
|
AU760113C
(en)
|
1997-11-18 |
2004-04-22 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods for genetic modification of plants
|
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
CA2370477C
(en)
|
1999-04-15 |
2010-06-29 |
Crucell Holland B.V. |
Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
|
|
EP1183344A4
(en)
|
1999-05-27 |
2003-06-25 |
Human Genome Sciences Inc |
ADAM POLYNUCLEOTIDES AND POLYPEPTIDES
|
|
GB0001448D0
(en)
|
2000-01-21 |
2000-03-08 |
Novartis Ag |
Organic compounds
|
|
CA2401965A1
(en)
|
2000-02-29 |
2001-09-07 |
Auburn University |
Production of antibodies in transgenic plastids
|
|
CN101498731A
(zh)
|
2000-05-18 |
2009-08-05 |
日本烟草产业株式会社 |
抗协同刺激信号转导分子ailim的人单克隆抗体及其药物用途
|
|
JP2004504055A
(ja)
|
2000-07-21 |
2004-02-12 |
アメリカ合衆国 |
真核生物ゲノムにおけるｄｎａの置換、転座およびスタッキングの方法
|
|
CA2422155A1
(en)
|
2000-08-03 |
2002-02-14 |
Wim Van Schooten |
Production of humanized antibodies in transgenic animals
|
|
EP1184458A1
(en)
|
2000-08-28 |
2002-03-06 |
U-BISys B.V. |
Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof
|
|
US20020119148A1
(en)
|
2000-09-01 |
2002-08-29 |
Gerritsen Mary E. |
ErbB4 antagonists
|
|
DE60125381T2
(de)
|
2000-09-08 |
2007-04-12 |
Massachusetts Institute Of Technology, Cambridge |
Zusammensetzungen und verfahren mit analogen von g-csf
|
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
JP2004531217A
(ja)
|
2001-01-05 |
2004-10-14 |
ファイザー・インク |
インスリン様成長因子ｉ受容体に対する抗体
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US6961875B2
(en)
|
2001-03-22 |
2005-11-01 |
International Business Machines Corporation |
Method and apparatus for capturing event traces for debug and analysis
|
|
GB0110029D0
(en)
|
2001-04-24 |
2001-06-13 |
Grosveld Frank |
Transgenic animal
|
|
US7034134B2
(en)
|
2001-04-26 |
2006-04-25 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
|
|
CN100448992C
(zh)
|
2001-05-11 |
2009-01-07 |
麒麟医药株式会社 |
含人抗体λ轻链基因的人类人工染色体
|
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
|
JP4303105B2
(ja)
|
2001-06-28 |
2009-07-29 |
ドマンティス リミテッド |
二重特異性リガンドとその利用
|
|
WO2004003019A2
(en)
|
2002-06-28 |
2004-01-08 |
Domantis Limited |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
|
EP2298809A3
(en)
|
2001-07-12 |
2012-02-15 |
FOOTE, Jefferson |
Super humanized antibodies
|
|
FR2827302B1
(fr)
|
2001-07-13 |
2003-10-10 |
Genoway |
Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
|
|
CA2898314A1
(en)
|
2001-07-19 |
2003-07-31 |
Perian Therapeutics, Inc. |
Multimeric proteins and methods of making and using same
|
|
ATE476504T1
(de)
|
2001-10-01 |
2010-08-15 |
Deutsches Krebsforsch |
Verfahren zur herstellung von protein- bibliotheken und zur selektion von proteinen daraus
|
|
US20060199204A1
(en)
|
2001-10-05 |
2006-09-07 |
U.S. Epa |
Genetic testing for male factor infertility
|
|
WO2003031656A1
(en)
|
2001-10-05 |
2003-04-17 |
United States Environmental Protection Agency |
Genetic testing for male factor infertility
|
|
EP1461442B1
(en)
|
2001-11-30 |
2017-09-06 |
Amgen Fremont Inc. |
Transgenic animals bearing human ig lambda light chain genes
|
|
DE60226641D1
(de)
|
2001-12-03 |
2008-06-26 |
Amgen Fremont Inc |
Antikörperkategorisierung auf der grundlage von bindungseigenschaften
|
|
GB0130267D0
(en)
|
2001-12-19 |
2002-02-06 |
Neutec Pharma Plc |
Focussed antibody technology
|
|
US20050095712A1
(en)
|
2002-01-17 |
2005-05-05 |
Alberto Martin |
Mutations caused by activation-induced cytidine deaminase
|
|
AU2003201093A1
(en)
|
2002-01-18 |
2003-07-30 |
Inovio As |
Bispecific antibody dna constructs for intramuscular administration
|
|
WO2003081993A2
(en)
|
2002-03-22 |
2003-10-09 |
Origen Therapeutics |
Transgenic aves producing human polyclonal antibodies
|
|
EP1505148B1
(en)
|
2002-04-26 |
2009-04-15 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of screening for agonistic antibodies
|
|
AU2003277087B2
(en)
|
2002-06-14 |
2008-07-31 |
Immunomedics, Inc. |
Humanized monoclonal antiboby hPAM4
|
|
JP2005536992A
(ja)
|
2002-06-28 |
2005-12-08 |
セントカー・インコーポレーテツド |
哺乳動物のｅｐｏ模倣ｃｈ１欠失ミメティボディ、組成物、方法および使用
|
|
CN101962408A
(zh)
|
2002-07-12 |
2011-02-02 |
杰斐逊·富特 |
超人源化抗体
|
|
PT2314629E
(pt)
|
2002-07-18 |
2014-01-22 |
Merus B V |
Produção recombinante de misturas de anticorpos
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
AR042145A1
(es)
|
2002-11-27 |
2005-06-08 |
Dow Agrociences Llc |
Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
|
|
GB0228210D0
(en)
|
2002-12-03 |
2003-01-08 |
Babraham Inst |
Single chain antibodies
|
|
GB0230201D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Retargeting
|
|
GB0230203D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
|
AU2003290330A1
(en)
|
2002-12-27 |
2004-07-22 |
Domantis Limited |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
|
EP1439234A1
(en)
|
2003-01-08 |
2004-07-21 |
ARTEMIS Pharmaceuticals GmbH |
Targeted transgenesis using the rosa26 locus
|
|
JP4477579B2
(ja)
|
2003-01-21 |
2010-06-09 |
中外製薬株式会社 |
抗体の軽鎖スクリーニング方法
|
|
CA2514417A1
(en)
|
2003-01-28 |
2004-08-12 |
Cellectis |
Custom-made meganuclease and use thereof
|
|
GB2398784B
(en)
|
2003-02-26 |
2005-07-27 |
Babraham Inst |
Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
|
|
JP2006520610A
(ja)
|
2003-03-04 |
2006-09-14 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
ハイブリッド不変領域を産生するのに用いるベクター
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
WO2004106375A1
(en)
|
2003-05-30 |
2004-12-09 |
Merus Biopharmaceuticals B.V. I.O. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
|
WO2005001087A2
(en)
|
2003-06-11 |
2005-01-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying genes in eukaryotic cells
|
|
EP1644417B1
(en)
|
2003-07-15 |
2014-04-30 |
Therapeutic Human Polyclonals, Inc. |
Humanized immunoglobulin loci
|
|
WO2005019463A1
(en)
|
2003-08-11 |
2005-03-03 |
Therapeutic Human Polyclonals, Inc. |
Improved transgenesis with humanized immunoglobulin loci
|
|
RU2251699C1
(ru)
|
2003-09-25 |
2005-05-10 |
Киселев Всеволод Иванович |
Способ ранней и доклинической диагностики цервикального рака
|
|
WO2005038001A2
(en)
|
2003-10-14 |
2005-04-28 |
Therapeutic Human Polyclonals, Inc. |
Improved transgenesis by sperm-mediated gene transfer
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
ES2364147T3
(es)
|
2004-01-16 |
2011-08-25 |
Regeneron Pharmaceuticals, Inc. |
Polipéptidos de fusión capaces de activar receptores.
|
|
CN1560081A
(zh)
|
2004-02-17 |
2005-01-05 |
大连帝恩生物工程有限公司 |
用能产生人IgGl重链－κ轻链小鼠作为制备人源化单克隆抗体和应用
|
|
US7625549B2
(en)
|
2004-03-19 |
2009-12-01 |
Amgen Fremont Inc. |
Determining the risk of human anti-human antibodies in transgenic mice
|
|
WO2006008548A2
(en)
|
2004-07-22 |
2006-01-26 |
Erasmus University Medical Centre Rotterdam |
Binding molecules
|
|
WO2006039418A2
(en)
|
2004-09-30 |
2006-04-13 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor ii (cd32)
|
|
DK2767161T3
(en)
|
2004-10-19 |
2018-05-07 |
Regeneron Pharma |
Method of generating an animal homozygous for genetic modification
|
|
AU2005333602B2
(en)
|
2004-10-22 |
2012-04-12 |
Medimmune, Llc |
High affinity antibodies against HMGB1 and methods of use thereof
|
|
WO2006047367A2
(en)
|
2004-10-22 |
2006-05-04 |
Therapeutic Human Polyclonals, Inc. |
Suppression of endogenous immunoglubolin expression in non-human transgenic animals
|
|
US20080196112A1
(en)
|
2005-04-29 |
2008-08-14 |
Innate Pharma, S.A. |
Transgenic Animals and Methods of Making Recombinant Antibodies
|
|
JP2008545375A
(ja)
|
2005-05-14 |
2008-12-18 |
フダン ユニバーシテイ |
脊椎動物の遺伝子操作および解析のための手段としてのｐｉｇｇｙＢａｃ
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
JP5525729B2
(ja)
|
2005-11-28 |
2014-06-18 |
ゲンマブ エー／エス |
組換え一価抗体およびその作製方法
|
|
WO2007065433A2
(en)
|
2005-12-05 |
2007-06-14 |
Symphogen A/S |
Anti-orthopoxvirus recombinant polyclonal antibody
|
|
EP1991580A2
(en)
|
2006-01-25 |
2008-11-19 |
Erasmus University Medical Center Rotterdam |
Generation of heavy-chain only antibodies in transgenic animals
|
|
GB0618345D0
(en)
|
2006-09-18 |
2006-10-25 |
Univ Erasmus |
Binding molecules
|
|
US7462759B2
(en)
|
2006-02-03 |
2008-12-09 |
Pioneer Hi-Bred International, Inc. |
Brittle stalk 2 gene family and related methods and uses
|
|
EP2322931A3
(en)
|
2006-03-22 |
2011-08-31 |
Viral Logic Systems Technology Corp. |
Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
|
|
JP5514539B2
(ja)
|
2006-03-31 |
2014-06-04 |
メダレックス・リミテッド・ライアビリティ・カンパニー |
ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物
|
|
JP5307708B2
(ja)
|
2006-06-02 |
2013-10-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒトｉｌ−６受容体に対する高親和性抗体
|
|
JP2010501165A
(ja)
|
2006-08-22 |
2010-01-21 |
ジーツー インフラメイション プロプライエタリー リミテッド |
抗体の作製方法
|
|
ATE536374T1
(de)
|
2006-09-01 |
2011-12-15 |
Therapeutic Human Polyclonals Inc |
Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
|
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
CA2664343C
(en)
|
2006-10-02 |
2016-04-26 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human il-4 receptor
|
|
RU2448979C2
(ru)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Антитела человека к дельта-подобному лиганду-4 человека
|
|
GB0700194D0
(en)
|
2007-01-05 |
2007-02-14 |
Univ Edinburgh |
Humanisation of animals
|
|
CN101688228B
(zh)
|
2007-03-13 |
2014-12-24 |
国家犾太健康中心 |
抗体产生的方法
|
|
GB0706628D0
(en)
|
2007-04-04 |
2007-05-16 |
Univ Erasmus |
Germ-line manipulation 1
|
|
EP2336329B8
(en)
|
2007-06-01 |
2012-11-21 |
Omt, Inc. |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenis human idiotype antibodies
|
|
US20090042254A1
(en)
|
2007-06-08 |
2009-02-12 |
Dow Global Technologies Inc. |
Expression of soluble antibody fragment by truncation of ch1 domain
|
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
|
ITMI20071522A1
(it)
|
2007-07-27 |
2009-01-28 |
Areta Internat S R L |
Vaccino idiotipico
|
|
KR20100058509A
(ko)
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
|
EP2185692A4
(en)
|
2007-08-10 |
2012-05-02 |
Medarex Inc |
HCO32 AND HCO27 AND RELATED EXAMPLES
|
|
WO2009023270A2
(en)
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
CN101842115B
(zh)
*
|
2007-08-29 |
2014-07-30 |
塞诺菲-安万特股份有限公司 |
人源化的抗-cxcr5抗体、其衍生物及它们的应用
|
|
US8426565B2
(en)
|
2007-08-30 |
2013-04-23 |
Walter And Eliza Hall Institute Of Medical Research |
Dendritic cell marker and uses thereof
|
|
EP3753947A1
(en)
|
2007-09-14 |
2020-12-23 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
TWI464262B
(zh)
|
2007-09-26 |
2014-12-11 |
中外製藥股份有限公司 |
抗體固定區的變異
|
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
|
WO2009051974A1
(en)
|
2007-10-17 |
2009-04-23 |
Nuvelo, Inc. |
Antibodes to cll-1
|
|
CN105001333B
(zh)
|
2007-12-14 |
2019-05-17 |
诺沃—诺迪斯克有限公司 |
抗人nkg2d抗体及其用途
|
|
AU2009204501B2
(en)
|
2008-01-07 |
2015-02-12 |
Amgen Inc. |
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
|
|
WO2009129247A2
(en)
|
2008-04-14 |
2009-10-22 |
Innovative Targeting Solutions Inc. |
Sequence diversity generation in immunoglobulins
|
|
EP2669298A3
(en)
*
|
2008-05-23 |
2014-02-26 |
Ablexis, LLC |
Single variable immunoglobulin domain comprising VL-DH-JL
|
|
US20100122358A1
(en)
*
|
2008-06-06 |
2010-05-13 |
Crescendo Biologics Limited |
H-Chain-only antibodies
|
|
HUE057994T2
(hu)
|
2008-06-27 |
2022-06-28 |
Merus Nv |
Antitesttermelõ, transzgenikus, egérfélékhez tartozó állat
|
|
LT2346994T
(lt)
|
2008-09-30 |
2022-03-10 |
Ablexis, Llc |
Knock-in pelė, skirta chimerinių antikūnų gamybai
|
|
JP2012508017A
(ja)
|
2008-11-07 |
2012-04-05 |
ファブラス エルエルシー |
抗ｄｌｌ４抗体及びその使用
|
|
MX2011007660A
(es)
|
2008-12-18 |
2011-08-17 |
Kingdon Craig R |
Animales transgenicos no humanos que expresan anticuerpos humanizados y usos de los mismos.
|
|
WO2010091182A2
(en)
|
2009-02-04 |
2010-08-12 |
Molecular Innovations |
Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
|
|
JP2012518398A
(ja)
|
2009-02-24 |
2012-08-16 |
グラクソ グループ リミテッド |
抗原結合性構築物
|
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
|
BRPI1014474A2
(pt)
|
2009-04-07 |
2017-06-27 |
Roche Glycart Ag |
anticorpos biespecíficos anti-erbb-1/anti-c-met.
|
|
SG174862A1
(en)
*
|
2009-04-10 |
2011-11-28 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorder
|
|
CN102449149B
(zh)
|
2009-05-29 |
2014-04-23 |
莫佛塞斯公司 |
集合及其使用方法
|
|
KR102010827B1
(ko)
|
2009-06-26 |
2019-08-14 |
리제너론 파마슈티칼스 인코포레이티드 |
천연 면역글로불린 포맷을 가지는 용이하게 분리된 이중특이성 항체
|
|
PT2564695E
(pt)
|
2009-07-08 |
2015-06-03 |
Kymab Ltd |
Modelos animais e moléculas terapêuticas
|
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
NZ600002A
(en)
|
2009-11-17 |
2014-08-29 |
Sanford Applied Biosciences L L C |
Human artificial chromosome vector
|
|
MY172472A
(en)
|
2009-12-10 |
2019-11-26 |
Regeneron Pharma |
Mice that make heavy chain antibodies
|
|
CN102762590B
(zh)
|
2009-12-21 |
2015-11-25 |
瑞泽恩制药公司 |
人源化的FcγR小鼠
|
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
|
US20130185821A1
(en)
|
2010-02-08 |
2013-07-18 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
|
CA2789154C
(en)
*
|
2010-02-08 |
2024-06-11 |
Regeneron Pharmaceuticals, Inc. |
Common light chain mouse
|
|
EP2569337A1
(en)
|
2010-05-14 |
2013-03-20 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
|
CN103228130B
(zh)
|
2010-06-17 |
2016-03-16 |
科马布有限公司 |
动物模型及治疗分子
|
|
ME03386B
(me)
|
2010-06-22 |
2020-01-20 |
Regeneron Pharma |
Hibridni laki lanac imunoglobulina koji ispoljavaju miševi
|
|
RU2612903C2
(ru)
|
2010-08-02 |
2017-03-13 |
Ридженерон Фармасьютикалз, Инк. |
Мыши, у которых вырабатываются связывающие белки, содержащие vl-домены
|
|
EP2638155A1
(en)
|
2010-11-08 |
2013-09-18 |
Kymab Limited |
Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
|
|
PL4067496T3
(pl)
|
2011-02-25 |
2023-07-31 |
Regeneron Pharmaceuticals, Inc. |
Myszy adam6
|
|
CN103403025B
(zh)
|
2011-02-28 |
2016-10-12 |
弗·哈夫曼-拉罗切有限公司 |
单价抗原结合蛋白
|
|
RU2607038C2
(ru)
|
2011-02-28 |
2017-01-10 |
Ф. Хоффманн-Ля Рош Аг |
Антигенсвязывающие белки
|
|
RS66089B1
(sr)
|
2011-08-05 |
2024-11-29 |
Regeneron Pharma |
Humanizovani miševi univerzalnog lakog lanca
|
|
JP2014531452A
(ja)
|
2011-09-19 |
2014-11-27 |
カイマブ・リミテッド |
動物、レパートリーおよび方法
|
|
EP3839049A3
(en)
|
2011-09-19 |
2021-10-20 |
Kymab Limited |
Antibodies, variable domains & chains tailored for human use
|
|
CA2791109C
(en)
|
2011-09-26 |
2021-02-16 |
Merus B.V. |
Generation of binding molecules
|
|
EP2761008A1
(en)
|
2011-09-26 |
2014-08-06 |
Kymab Limited |
Chimaeric surrogate light chains (slc) comprising human vpreb
|
|
RU2743589C2
(ru)
|
2011-10-17 |
2021-02-20 |
Регенерон Фармасьютикалс, Инк. |
Мыши с ограниченной тяжелой цепью иммуноглобулина
|
|
GB2496375A
(en)
|
2011-10-28 |
2013-05-15 |
Kymab Ltd |
A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
SI2793567T1
(sl)
|
2011-12-20 |
2019-05-31 |
Regeneron Pharmaceuticals, Inc. |
Humanizirane lahkoverižne miši
|
|
HRP20192218T1
(hr)
|
2012-02-01 |
2020-03-06 |
Regeneron Pharmaceuticals, Inc. |
Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
|
|
JP2015509380A
(ja)
|
2012-03-06 |
2015-03-30 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
共通の軽鎖のマウス
|
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
|
PT2838918T
(pt)
|
2012-04-20 |
2019-08-23 |
Merus Nv |
Métodos e meios para a produção de moléculas heterrodiméricas do tipo ig
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
EP2967013B1
(en)
|
2013-03-13 |
2019-01-16 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
KR20150126863A
(ko)
|
2013-03-13 |
2015-11-13 |
리제너론 파마슈티칼스 인코포레이티드 |
공통 경쇄 마우스
|
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
LT2986729T
(lt)
|
2013-04-16 |
2018-10-25 |
Regeneron Pharmaceuticals, Inc. |
Žiurkės genomo tikslinė modifikacija
|
|
CN106164092A
(zh)
|
2014-03-21 |
2016-11-23 |
瑞泽恩制药公司 |
表现不同结合特征的vl抗原结合蛋白
|
|
EP3895528A1
(en)
*
|
2014-03-21 |
2021-10-20 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that make single domain binding proteins
|
|
JP2018508224A
(ja)
|
2015-03-19 |
2018-03-29 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
抗原を結合する軽鎖可変領域を選択する非ヒト動物
|